<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04276324</url>
  </required_header>
  <id_info>
    <org_study_id>UCAM</org_study_id>
    <nct_id>NCT04276324</nct_id>
  </id_info>
  <brief_title>Effects of Ten-Weeks Power Training on Neuromuscular Performance, Heart Rate Variability, Sleep Quality and Mobility in Persons With Multiple Sclerosis</brief_title>
  <official_title>Effects of Ten-Weeks Resistance Training on Neuromuscular Performance, Heart Rate Variability, Sleep Quality and Mobility in Persons With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Católica San Antonio de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Católica San Antonio de Murcia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease
      of the central nervous system, characterized by demyelination due to inflammation and
      degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter,
      brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic
      fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems.
      Strength training has been shown to improve strength and mobility in persons with MS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal Voluntary Isometric Contraction of Knee Extension</measure>
    <time_frame>Before the program training</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal Voluntary Isometric Contraction of Knee Extension</measure>
    <time_frame>After 10 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of Force Development</measure>
    <time_frame>Before the program training</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of Force Development</measure>
    <time_frame>After 10 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Activation Ratio</measure>
    <time_frame>Before the program training</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Activation Ratio</measure>
    <time_frame>After 10 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Spasticity</measure>
    <time_frame>Before the program training</time_frame>
    <description>Pendulum test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spasticity</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Pendulum test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking speed</measure>
    <time_frame>Before the program training</time_frame>
    <description>Test 10 m-walks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking speed</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Test 10 m-walks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static balance</measure>
    <time_frame>Before the program training</time_frame>
    <description>Romberg Test with eyes open and closed. Analysis with force plates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Static balance</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Romberg Test with eyes open and closed. Analysis with force plates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>Before the program training</time_frame>
    <description>Sit to stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Sit to stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>Before the program training</time_frame>
    <description>Sleeping Heart Rate Variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Sleeping Heart Rate Variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>Before the program training</time_frame>
    <description>Karolinska Sleep Diary and Acelerometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>After 10 weeks</time_frame>
    <description>Karolinska Sleep Diary and Acelerometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only testing sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten weeks of resistance training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance training</intervention_name>
    <description>Ten weeks of resistance training</description>
    <arm_group_label>Resistance training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Testing sessions</intervention_name>
    <description>Testing sessions</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Resistance training group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild or moderate disability with clinical mild spastic-ataxic gait disorder.

          -  stable phase of the disease.

        Exclusion Criteria:

          -  Expanded Disability Status Scale (EDSS) &lt; 6.

          -  relapsing disease within the preceding 12 months.

          -  corticosteroid treatment within the last months before study inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacobo Á Rubio-Arias, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Católica San Antonio de Murcia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Católica San Antonio</name>
      <address>
        <city>Murcia</city>
        <zip>30107</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Andreu Caravaca, MsC, PhD Candidate</last_name>
      <phone>697661913</phone>
      <email>landreu@ucam.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Católica San Antonio de Murcia</investigator_affiliation>
    <investigator_full_name>Jacobo Á. Rubio</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be published in a journal</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After the completion of the study</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

